policy
KAIST and the government of Sejong City will cooperate to establish a graduate school of medical science and engineering. On June 11, 2015, President Steve Kang of KAIST and Mayor Choon-Hee Lee of Sejong City signed a memorandum of understanding at the city hall of Sejong to establish the school.
Under the agreement, the two organizations will work out details to establish the graduate school in Sejong on such issues as administrative assistance, financial support, curriculum development, and the creation of an environment conducive to the growth of medical science.
President Kang said, “Once this graduate school is established, KAIST will be able to offer Korea and the world top-notch researchers in the field of medical science. I have high hopes that the school will produce high-impact research breakthroughs and lead in the advancement of interdisciplinary studies in biotechnology.”
In the picture below, President Steve Kang of KAIST (third from the left) holds the signed memorandum of understanding with Mayor Choon-Hee Lee of Sejong (fourth from the left).
-
event Department of Industrial Design Signs MOU with Rosso Sungsimdang for Design Education and Research Collaboration
< Participants shouting ‘Bread!’ to celebrate the signing of the MOU > The Department of Industrial Design at KAIST signed a Memorandum of Understanding (MOU) for industry-academic cooperation with Rosso Sungsimdang on February 24, 2026. This agreement was pursued to combine the unique creativity and technical expertise of each field to promote mutual growth and establish a cooperative system to lead innovation in cultural industry design. The ceremony, held at the KAIST De
2026-02-26 -
research AI Opens a New Era in Medical Science and Bio
< (From left) KAIST Professors Yoonjae Choi, Tae-Kyun Kim, Jong Chul Ye, Hyunwoo Kim, Seunghoon Hong, Sang Yup Lee > KAIST announced on the 14th of November that it has been selected as a major participating institution in the 'Lunit Consortium' for the 'AI Specialized Foundation Model Development Project' supervised by the Ministry of Science and ICT, and has officially started developing an AI foundation model for the medical science and bio fields. Through this project, KAIST plans
2025-11-14 -
research KAIST Uncovers the Mechanism Behind Overactive Immune Cells
<(From Right) Professor Eui-Cheol Shin, Ph.D candidate So-Young Kim, Professor Su-Hyung Park, Professor Hyuk Soo Eun, Dr. Hoyoung Lee> “Why do immune cells that are supposed to eliminate viruses suddenly turn against our own body?” There are instances where killer T cells—which are meant to precisely remove virus-infected cells—malfunction like overheated engines, attacking even healthy cells and damaging tissues. A KAIST research team has now identified the ke
2025-11-06 -
event KAIST VIRNECT Sign Agreement to Establish Virtual Convergence Research Center
< (From left) Tae Jin Ha, CEO of VIRNECT, Kwang Hyung Lee, President of KAIST > An open platform for industry-academia-research collaboration, which has accumulated K-Metaverse technology capabilities that break down the boundaries between reality and virtuality and share experiences beyond the limits of time and space, is expected to be built on our university campus. Our university announced on the 13th that it’s signing an agreement for the establishment and operation of a 'Vi
2025-10-13 -
research KAIST Exports Global License for New Drug Candidate for Intractable Epilepsy Worth 750 Billion KRW
<(From Left) Professor Jeong Ho Lee, CEO Cheolwon Park, Principal Researcher Sang-min Park> KAIST (President Kwang Hyung Lee) announced on the 9th of October that Sovargen (co-led by CEOs Cheolwon Park and Jeong Ho Lee), a faculty startup led by Professor Jeong Ho Lee of the KAIST Graduate School of Medical Science and Engineering, has successfully achieved a global technology export deal worth a total of 750 billion KRW. The deal involves an innovative RNA-based new drug candidate for
2025-10-10